{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:53:24Z","timestamp":1775109204348,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,21]]},"DOI":"10.7759\/cureus.82673","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T09:03:11Z","timestamp":1745226191000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinico-Hematological Profile of Children and Adolescents With Chronic Myeloid Leukemia: A Study at a Tertiary Care Institute in India"],"prefix":"10.7759","author":[{"given":"Kaushal","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-648667","article-title":"Pediatric chronic myeloid leukemia is a unique disease that requires a different approach","volume":"127","author":"Hijiya N","year":"2016","unstructured":"Hijiya N, Schultz KR, Metzler M, Millot F, Suttorp M. Pediatric chronic myeloid leukemia is a unique disease that requires a different approach. Blood. 2016, 127:392-9. 10.1182\/blood-2015-06-648667","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2014.09.008","article-title":"Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions","volume":"62","author":"Hijiya N","year":"2015","unstructured":"Hijiya N, Millot F, Suttorp M. Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions. Pediatr Clin North Am. 2015, 62:107-19. 10.1016\/j.pcl.2014.09.008","journal-title":"Pediatr Clin North Am"},{"key":"ref3","article-title":"Cancer Incidence and Survival Among Children and Adolescents: United States Seer Program, 1975-1995","author":"Ries LAG","year":"1999","unstructured":"Ries LAG, Smith MA, Gurney JG, et al.. Cancer Incidence and Survival Among Children and Adolescents: United States Seer Program, 1975-1995. National Cancer Institute, SEER program, 1999."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu490","article-title":"Differences among young adults, adults and elderly chronic myeloid leukemia patients","volume":"26","author":"Castagnetti F","year":"2015","unstructured":"Castagnetti F, Gugliotta G, Baccarani M, et al.. Differences among young adults, adults and elderly chronic myeloid leukemia patients. Ann Oncol. 2015, 26:185-92. 10.1093\/annonc\/mdu490","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.7114","article-title":"Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial","volume":"29","author":"Millot F","year":"2011","unstructured":"Millot F, Baruchel A, Guilhot J, et al.. Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial. J Clin Oncol. 2011, 29:2827-32. 10.1200\/JCO.2010.32.7114","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Quint\u00e1s-Cardama A","year":"2009","unstructured":"Quint\u00e1s-Cardama A, Cortes J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood. 2009, 113:1619-30. 10.1182\/blood-2008-03-144790","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers CL","year":"1999","unstructured":"Sawyers CL. Chronic myeloid leukemia. N Engl J Med. 1999, 340:1330-40. 10.1056\/NEJM199904293401706","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.2866","article-title":"Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population","volume":"34","author":"Bower H","year":"2016","unstructured":"Bower H, Bj\u00f6rkholm M, Dickman PW, H\u00f6glund M, Lambert PC, Andersson TM. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J Clin Oncol. 2016, 34:2851-7. 10.1200\/JCO.2015.66.2866","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018882233","article-title":"How I treat chronic myeloid leukemia in children and adolescents","volume":"133","author":"Hijiya N","year":"2019","unstructured":"Hijiya N, Suttorp M. How I treat chronic myeloid leukemia in children and adolescents. Blood. 2019, 133:2374-84. 10.1182\/blood.2018882233","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0179-9","article-title":"Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial","volume":"32","author":"Suttorp M","year":"2018","unstructured":"Suttorp M, Schulze P, Glauche I, et al.. Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. Leukemia. 2018, 32:1657-69. 10.1038\/s41375-018-0179-9","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23031","article-title":"Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology Group","volume":"57","author":"Champagne MA","year":"2011","unstructured":"Champagne MA, Fu CH, Chang M, et al.. Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011, 57:56-62. 10.1002\/pbc.23031","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.9597","article-title":"Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a Phase II trial","volume":"36","author":"Gore L","year":"2018","unstructured":"Gore L, Kearns PR, de Martino ML, et al.. Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a Phase II trial. J Clin Oncol. 2018, 36:1330-8. 10.1200\/JCO.2017.75.9597","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/ijmpo.ijmpo_104_16","article-title":"Effectiveness of three prognostic scoring systems in predicting the response and outcome in pediatric chronic myeloid leukemia chronic phase on frontline imatinib","volume":"38","author":"Ganta RR","year":"2017","unstructured":"Ganta RR, Nasaka S, Linga VG, Gundeti S, Maddali LS, Digumarti RR. Effectiveness of three prognostic scoring systems in predicting the response and outcome in pediatric chronic myeloid leukemia chronic phase on frontline imatinib. Indian J Med Paediatr Oncol. 2017, 38:282-6. 10.4103\/ijmpo.ijmpo_104_16","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijpm.ijpm_462_21","article-title":"Pediatric and adolescent chronic myeloid leukemia: a follow-up study in western India","volume":"66","author":"Vanik SA","year":"2023","unstructured":"Vanik SA, Jetly D, Parikh B, Dhandapani K, Bezbaruah R. Pediatric and adolescent chronic myeloid leukemia: a follow-up study in western India. Indian J Pathol Microbiol. 2023, 66:560-3. 10.4103\/ijpm.ijpm_462_21","journal-title":"Indian J Pathol Microbiol"},{"key":"ref15","article-title":"Clinico - hematological profile and bone marrow correlation of chronic myeloid leukemia: a multiparameter study in a tertiary care hospital","volume":"9","author":"Kumar K","year":"2022","unstructured":"Kumar K, Agrawal R, Kumar S, Iffat Jamal S, Ranjan A, Choudhary VN. Clinico - hematological profile and bone marrow correlation of chronic myeloid leukemia: a multiparameter study in a tertiary care hospital. Eur J Mol Clin Med. 2022, 9:4687-8.","journal-title":"Eur J Mol Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/2278-330X.119891","article-title":"Chronic myeloid leukemia in children and adolescents: a single center experience from Eastern India","volume":"2","author":"Raut L","year":"2013","unstructured":"Raut L, Bohara VV, Ray SS, Chakrabarti P, Chaudhuri U. Chronic myeloid leukemia in children and adolescents: a single center experience from Eastern India. South Asian J Cancer. 2013, 2:260-4. 10.4103\/2278-330X.119891","journal-title":"South Asian J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ijmpo.ijmpo_62_17","article-title":"Biology of chronic myelogenous leukemia in childhood and young adolescents: an Indian perspective","volume":"39","author":"Chandra D","year":"2018","unstructured":"Chandra D, Singh J, Deka R, et al.. Biology of chronic myelogenous leukemia in childhood and young adolescents: an Indian perspective. Indian J Med Paediatr Oncol. 2018, 39:142-5. 10.4103\/ijmpo.ijmpo_62_17","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/ijh.ijh_28_17","article-title":"Evaluation of chronic myeloid leukemia patients and their molecular responses to tyrosine kinase inhibitors in Erbil city, Iraq","volume":"7","author":"Hasan K","year":"2018","unstructured":"Hasan K. Evaluation of chronic myeloid leukemia patients and their molecular responses to tyrosine kinase inhibitors in Erbil city, Iraq. Iraqi J Hematol. 2018, 7:1. 10.4103\/ijh.ijh_28_17","journal-title":"Iraqi J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348053-clinico-hematological-profile-of-children-and-adolescents-with-chronic-myeloid-leukemia-a-study-at-a-tertiary-care-institute-in-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T09:03:12Z","timestamp":1745226192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348053-clinico-hematological-profile-of-children-and-adolescents-with-chronic-myeloid-leukemia-a-study-at-a-tertiary-care-institute-in-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.82673","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}